- Presentations
- 0
- Brands
- 0
- Manufacturers
- 0
- Available from stock
- 0
Ertugliflozin and Sitagliptin is a medicine. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- ATC classification
- A10BD24 Ertugliflozin and Sitagliptin · Diabetes medicines, subgroup A10B, subgroup A10BD
- US FDA first approval
- 19 December 2017
- EU status
- Authorised
- Orphan designation
- No
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Fixed-dose combination of
- Ertugliflozin, Sitagliptin
- Identifiers
- RxCUI 1992825Q48566734
All presentations
No presentations of Ertugliflozin and Sitagliptin are listed yet. Ask us to source it
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Questions and answers
Is Ertugliflozin and Sitagliptin available for export from India?
No presentation of Ertugliflozin and Sitagliptin is listed yet, but our sourcing team can check licensed channels. Send a request with the strength, quantity and destination country.
Is Ertugliflozin and Sitagliptin approved by the US FDA?
Yes. The US FDA first approved Ertugliflozin and Sitagliptin on 19 December 2017, according to Drugs@FDA.
Is Ertugliflozin and Sitagliptin authorised in the European Union?
Yes. Ertugliflozin and Sitagliptin has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
Does Ertugliflozin and Sitagliptin need cold chain shipping?
No listed presentation of Ertugliflozin and Sitagliptin is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Ertugliflozin and Sitagliptin in?
Ertugliflozin and Sitagliptin is classified under ATC code A10BD24 (Ertugliflozin and Sitagliptin).
References
- Steglujan: European public assessment report (EPAR). European Medicines Agency. Retrieved 21 November 2025
Request Ertugliflozin and Sitagliptin for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.